Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biote (BTMD) EBITDA Margin (2021 - 2025)

Biote (BTMD) has 3 years of EBITDA Margin data on record, last reported at 12.27% in Q4 2023.

  • For Q4 2023, EBITDA Margin fell 482.0% year-over-year to 12.27%; the TTM value through Dec 2023 reached 7.23%, up 4940.0%, while the annual FY2024 figure was 0.51%, 1538.0% down from the prior year.
  • EBITDA Margin reached 12.27% in Q4 2023 per BTMD's latest filing, down from 17.1% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 41.58% in Q4 2021 and bottomed at 206.21% in Q2 2022.
  • Average EBITDA Margin over 3 years is 6.64%, with a median of 12.27% recorded in 2023.
  • Peak YoY movement for EBITDA Margin: crashed -20624bps in 2022, then skyrocketed 20621bps in 2023.
  • A 3-year view of EBITDA Margin shows it stood at 41.58% in 2021, then crashed by -59bps to 17.09% in 2022, then fell by -28bps to 12.27% in 2023.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 12.27% in Q4 2023, 17.1% in Q3 2023, and 0.0% in Q2 2023.